These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 12876642)
1. Oral anticoagulant therapy: should doctors change the way they give patients explanations? Marongiu F Thromb Haemost; 2003 Jul; 90(1):159-60. PubMed ID: 12876642 [No Abstract] [Full Text] [Related]
2. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases]. Katona A; Márk L Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862 [TBL] [Abstract][Full Text] [Related]
3. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Laporte S; Quenet S; Buchmüller-Cordier A; Reynaud J; Tardy-Poncet B; Thirion C; Decousus H; Mismetti P Thromb Haemost; 2003 Mar; 89(3):458-67. PubMed ID: 12624628 [TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. Patient self-management versus clinic management of oral blood thinner therapy. Ann Intern Med; 2005 Jan; 142(1):I14. PubMed ID: 15630100 [No Abstract] [Full Text] [Related]
5. The blue toe syndrome during oral anticoagulant therapy with acenocoumarol. Fernández MA; Andreu R; Fortea JM; Aznar J Thromb Haemost; 2001 Apr; 85(4):743. PubMed ID: 11341514 [No Abstract] [Full Text] [Related]
6. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK). Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929 [TBL] [Abstract][Full Text] [Related]
7. Activated recombinant factor VII to reverse oral anticoagulants for emergent cesarean delivery. Morante L; Guasch EV; Palacio F; Gilsanz F Anesth Analg; 2006 Jun; 102(6):1902-3. PubMed ID: 16717350 [No Abstract] [Full Text] [Related]
8. [Liver toxicity associated with oral anticoagulant treatment: report of two cases]. Walter T; Lot M; Guillaud O; Vial T; Boillot O; Dumortier J Gastroenterol Clin Biol; 2007; 31(6-7):615-6. PubMed ID: 17646791 [No Abstract] [Full Text] [Related]
9. [Knowledge of patients undergoing long-term acenocumarol treatment about the safety of anticoagulant therapy]. Sawicka-Powierza J; Ołtarzewska AM; Chlabicz S Pol Merkur Lekarski; 2007 Jan; 22(127):36-40. PubMed ID: 17477088 [TBL] [Abstract][Full Text] [Related]
10. [Level of knowledge among patients treated with oral anticoagulant]. Várnai R; Végh M; Pótó L; Nagy L Orv Hetil; 2008 Oct; 149(43):2047-51. PubMed ID: 18926963 [TBL] [Abstract][Full Text] [Related]
15. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157 [TBL] [Abstract][Full Text] [Related]
16. [Secondary drug toxiderma to acenocoumarol]. Khammassi N; Kessentini N Pan Afr Med J; 2015; 22():95. PubMed ID: 26848342 [No Abstract] [Full Text] [Related]
17. [Hemarthroses complicating anticoagulant therapy (heparin, oral anticoagulants)]. Gerster JC; Wauters JP; Waldburger M; Saudan Y Schweiz Med Wochenschr; 1977 Aug; 107(33):1170-2. PubMed ID: 897653 [TBL] [Abstract][Full Text] [Related]
18. Little-publicized Manitoba case holds crucial lesson for doctors. Capen K CMAJ; 1998 Jun; 158(11):1520-1. PubMed ID: 9629120 [No Abstract] [Full Text] [Related]
19. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients. Mazokopakis EE; Vrentzos GE; Ganotakis ES Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529 [TBL] [Abstract][Full Text] [Related]